Authors
Loading...
Preclinical study reveals matairesinol monoglucoside reduces hepatitis B viral markers in murine liver cells, indicating its therapeutic promise via STING activation.
Su et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: